Development of Antisense Drugs for Dyslipidemia

por Yamamoto, Tsuyoshi, Wada, Fumito, Harada-Shiba, Mariko
Publicado 2016

Superior Silencing by 2′,4′-BNA(NC)-Based Short Antisense Oligonucleotides Compared to 2′,4′-BNA/LNA-Based Apolipoprotein B Antisense Inhibitors

por Yamamoto, Tsuyoshi, Yasuhara, Hidenori, Wada, Fumito, Harada-Shiba, Mariko, Imanishi, Takeshi, Obika, Satoshi
Publicado 2012

Ca(2+) enrichment in culture medium potentiates effect of oligonucleotides

por Hori, Shin-ichiro, Yamamoto, Tsuyoshi, Waki, Reiko, Wada, Shunsuke, Wada, Fumito, Noda, Mio, Obika, Satoshi
Publicado 2015

Highly Potent GalNAc-Conjugated Tiny LNA Anti-miRNA-122 Antisense Oligonucleotides

por Yamamoto, Tsuyoshi, Mukai, Yahiro, Wada, Fumito, Terada, Chisato, Kayaba, Yukina, Oh, Kaho, Yamayoshi, Asako, Obika, Satoshi, Harada–Shiba, Mariko
Publicado 2021

Drug discovery and development scheme for liver-targeting bridged nucleic acid antisense oligonucleotides

por Wada, Fumito, Yamamoto, Tsuyoshi, Kobayashi, Tadayuki, Tachibana, Keisuke, Ito, Kosuke Ramon, Hamasaki, Mayumi, Kayaba, Yukina, Terada, Chisato, Yamayoshi, Asako, Obika, Satoshi, Harada-Shiba, Mariko
Publicado 2021

Antisense Oligonucleotides Targeting Y-Box Binding Protein-1 Inhibit Tumor Angiogenesis by Downregulating Bcl-xL-VEGFR2/-Tie Axes

por Setoguchi, Kiyoko, Cui, Lin, Hachisuka, Nobutaka, Obchoei, Sumalee, Shinkai, Kentaro, Hyodo, Fuminori, Kato, Kiyoko, Wada, Fumito, Yamamoto, Tsuyoshi, Harada-Shiba, Mariko, Obika, Satoshi, Nakano, Kenji
Publicado 2017